Grail Inc (GRAL) Stock Price, Quote & News

Company Profile

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therap...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 833 694 2553

Website: grail.com

Address:

1525 O’Brien Drive, Menlo Park, United States

sam92 May. 8 at 11:17 AM

$GRAL Getting closer to real approval . This is on of those ready to Scandisk run !

0 · Reply

prodigy81 May. 7 at 8:27 PM

$CAI $BLLN $GRAL Do they have common in cancer diagonisic area right?

0 · Reply

joedoe007 May. 6 at 5:17 PM

$GRAL Will GRAL run like SNDK or $MU or even loke $CNC

1 · Reply

GoCoogs May. 6 at 3:13 PM

$GRAL 7 million shares are short. Will they start to cover?

0 · Reply

prodigy81 May. 5 at 9:25 PM

$GRAL Hmm...I don't think this earning is that bad....but somehow people don't like it?

0 · Reply

1cashmoney May. 5 at 9:13 PM

$GRAL about as boring of an earnings reaction as this one could possibly get. I think everyone is waiting for the new data presentation to get some clarity on how likely fda approval may or may not be

0 · Reply

sam92 May. 5 at 8:50 PM

$GRAL Momentum Momentum for GRAL is strongly bullish. The 14-period Slow Stochastic oscillator is above 80, the level which many analysts call overbought. This means that investors have been actively purchasing shares and driving the price higher. As of 3:59 PM ET Tuesday, 05/05/2026

0 · Reply

sam92 May. 5 at 8:49 PM

$GRAL GRAIL to Present at the BofA Securities 2026 Health Care Conference 04:01:00 PM ET, 04/30/2026 - PR Newswire

0 · Reply

StocktwitsEarnings May. 5 at 8:11 PM

$GRAL Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$2.29 up 26.13% YoY • Reported revenue of $40.78M up 28.11% YoY

0 · Reply

AStrokeOfLuck May. 5 at 8:07 PM

$GRAL

0 · Reply

Grail price target lowered to $70 from $82 at Baird

2026-05-07T07:52:29.000Z - 1 day ago

Grail price target raised to $56 from $54 at Piper Sandler

2026-05-07T05:21:56.000Z - 1 day ago

Grail price target raised to $69 from $65 at TD Cowen

May 6, 2026, 10:00 AM EDT - 2 days ago

Zaya Younan Unveils the Scientific Holy Grail of Cigar Smoking

2026-05-05T20:33:50.000Z - 3 days ago

Grail reports Q1 EPS ($2.29), consensus ($1.96)

May 5, 2026, 4:30 PM EDT - 3 days ago

GRAIL Earnings Call Transcript: Q1 2026

May 5, 2026, 4:01 PM EDT - 3 days ago

GRAIL Reports First Quarter 2026 Financial Results

Apr 30, 2026, 4:01 PM EDT - 8 days ago

GRAIL to Present at the BofA Securities 2026 Health Care Conference

Apr 22, 2026, 4:01 PM EDT - 16 days ago

GRAIL to Announce First Quarter 2026 Financial Results

Apr 21, 2026, 4:53 PM EDT - 17 days ago

GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at 2026 ASCO Annual Meeting

2026-04-10T09:55:12.000Z - 4 weeks ago

Grail initiated with a Neutral at Mizuho

2026-04-10T08:45:11.000Z - 4 weeks ago

Grail initiated with a Neutral at Piper Sandler

2026-04-07T20:05:13.000Z - 4 weeks ago

Grail announces collaboration with Epic to bring Galleri test to EHR platforms

Apr 7, 2026, 4:01 PM EDT - 4 weeks ago

GRAIL Announces Integration of the Galleri® Test into Epic Electronic Health Record Platform to Expand Access Nationwide

Apr 3, 2026, 3:18 PM EDT - 5 weeks ago

GRAL Investors Have Opportunity to Join GRAIL, Inc. Fraud Investigation with the Schall Law Firm

2026-04-01T17:15:43.000Z - 5 weeks ago

Grail, Superpower partner to expand early cancer detection

Apr 1, 2026, 1:09 PM EDT - 5 weeks ago

Cancer Is Striking Earlier -- Superpower and GRAIL Are Partnering to Expand Early Detection

2026-03-30T11:54:36.000Z - 5 weeks ago

Grail price target lowered to $75 from $130 at Guggenheim

2026-03-18T09:45:11.000Z - 7 weeks ago

Grail upgraded to Buy from Hold at TD Cowen

Mar 12, 2026, 6:13 PM EDT - 2 months ago

Grail CEO Bob Ragusa to retire, Josh Ofman named successor

2026-03-12T20:41:38.000Z - 2 months ago

Grail CEO Bob Ragusa retiring, Josh Ofman appointed successor

Mar 12, 2026, 4:30 PM EDT - 2 months ago

GRAIL Announces Retirement of CEO Bob Ragusa and Appointment of Josh Ofman, MD, MSHS, as Successor

Mar 5, 2026, 9:00 AM EST - 2 months ago

Levi & Korskinsky, LLP: Grail (GRAL) Guided to 2030 Cash Runway While Key Trial Risk Went Unaddressed

Mar 3, 2026, 10:30 AM EST - 2 months ago

GRAIL Transcript: TD Cowen 46th Annual Health Care Conference

Mar 2, 2026, 4:01 PM EST - 2 months ago

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Feb 24, 2026, 4:02 PM EST - 2 months ago

GRAIL to Present at the TD Cowen 46th Annual Health Care Conference

2026-02-24T17:07:19.000Z - 2 months ago

Grail rises 14.9%

2026-02-24T12:51:30.000Z - 2 months ago

Grail price target lowered to $60 from $110 at Morgan Stanley

2026-02-23T17:06:32.000Z - 2 months ago

Grail falls -13.5%

2026-02-23T15:07:00.000Z - 2 months ago

Grail falls -14.1%

2026-02-23T14:46:56.000Z - 2 months ago

Unusually active option classes on open February 23rd

FRO FSLY OPEN QUBT SLS VKTX VNDA

Feb 23, 2026, 9:06 AM EST - 2 months ago

'Holy Grail' Honus Wagner card sells for over $5M as family auctions it from grandfather's collection

Feb 20, 2026, 4:26 PM EST - 2 months ago

This once-hot cancer-detection company's stock got cut in half after a failed trial

2026-02-20T17:06:42.000Z - 2 months ago

Grail falls -47.9%

Feb 20, 2026, 8:35 AM EST - 2 months ago

Grail shares plunge after major cancer screening trial misses main goal

Feb 20, 2026, 4:06 AM EST - 2 months ago

Grail Stock Plunges 50% After Earnings. But It's These Test Results That Are to Blame.

Feb 19, 2026, 9:27 PM EST - 2 months ago

Grail Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Feb 19, 2026, 5:00 PM EST - 2 months ago

GRAIL Earnings Call Transcript: Q4 2025

Feb 19, 2026, 4:02 PM EST - 2 months ago

GRAIL Reports Fourth Quarter and Full Year 2025 Financial Results

Feb 19, 2026, 4:01 PM EST - 2 months ago

Landmark NHS-Galleri Trial Demonstrates a Substantial Reduction in Stage IV Cancer Diagnoses, Increased Stage I and II Detection of Deadly Cancers, and Four-Fold Higher Cancer Detection Rate

Feb 16, 2026, 9:00 AM EST - 2 months ago

GRAIL to Announce Fourth Quarter and Full Year 2025 Financial Results

Jan 29, 2026, 7:25 PM EST - 3 months ago

GRAIL Submits FDA Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test

Jan 26, 2026, 8:00 AM EST - 3 months ago

A Study on Aging Unlocks Holy Grail of Sports Performance

Jan 12, 2026, 10:30 AM EST - 4 months ago

GRAIL Transcript: 44th Annual J.P. Morgan Healthcare Conference

Dec 15, 2025, 4:01 PM EST - 5 months ago

GRAIL to Present at the 44th Annual J.P. Morgan Healthcare Conference

Dec 2, 2025, 3:00 PM EST - 5 months ago

GRAIL Transcript: Piper Sandler 37th Annual Healthcare Conference

Nov 24, 2025, 9:11 AM EST - 5 months ago

Deutsche Bank may have just set a holy-grail goal for the S&P 500

DB IVV SPXL SPY SSO UPRO VOO

Nov 18, 2025, 4:02 PM EST - 6 months ago

GRAIL to Present at Piper Sandler 37th Annual Healthcare Conference

Nov 18, 2025, 10:00 AM EST - 6 months ago

GRAIL Transcript: Wolfe Research Healthcare Conference 2025

Nov 13, 2025, 11:00 AM EST - 6 months ago

GRAIL Transcript: Analyst Day

Nov 12, 2025, 4:30 PM EST - 6 months ago

GRAIL Earnings Call Transcript: Q3 2025

Nov 12, 2025, 4:02 PM EST - 6 months ago

GRAIL Reports Third Quarter 2025 Financial Results

Nov 4, 2025, 4:02 PM EST - 6 months ago

GRAIL to Present at 7th Annual Wolfe Research Healthcare Conference

Oct 29, 2025, 4:02 PM EDT - 6 months ago

GRAIL to Announce Third Quarter 2025 Financial Results

Oct 22, 2025, 8:05 PM EDT - 7 months ago

Odds of these speculative stocks making you money seems very slim, says Jim Cramer

ASTS TGEN TMQ AUR RGTI

Oct 20, 2025, 8:00 AM EDT - 7 months ago

GRAIL Transcript: Study Result

Oct 20, 2025, 6:30 AM EDT - 7 months ago

GRAIL, Inc. Announces $325.0 Million Private Placement Financing

Oct 20, 2025, 6:00 AM EDT - 7 months ago

GRAIL and University of Oxford to Present Long-Term Data From the SYMPLIFY Study Evaluating the Galleri® Multi-Cancer Early Detection Test in Symptomatic Individuals at the Early Detection of Cancer Conference (EDCC)

Oct 17, 2025, 6:08 PM EDT - 7 months ago

GRAIL PATHFINDER 2 Results Show Galleri ® Multi-Cancer Early Detection Blood Test Increased Cancer Detection More Than Seven-Fold When Added to USPSTF A and B Recommended Screenings

Oct 17, 2025, 9:55 AM EDT - 7 months ago

What's Happening With GRAIL Stock?

Oct 16, 2025, 8:22 AM EDT - 7 months ago

Samsung and GRAIL Announce Strategic Collaboration to Bring GRAIL's Galleri® Multi-Cancer Early Detection Test to Asia

Sep 24, 2025, 8:00 AM EDT - 8 months ago

GRAIL Transcript: Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum

Sep 23, 2025, 9:01 AM EDT - 8 months ago

GRAIL to Present New Galleri® Data From More Than 32,000 Participants Across the PATHFINDER 2, SYMPLIFY and REFLECTION Studies at ESMO Congress 2025 and EDCC

Sep 19, 2025, 8:47 AM EDT - 8 months ago

Sun World International and Pairwise Launch Strategic Partnership to Develop a Holy Grail of Produce – the Pitless Cherry

Sep 10, 2025, 4:02 PM EDT - 8 months ago

GRAIL to Present at Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum

Sep 9, 2025, 1:50 PM EDT - 8 months ago

GRAIL Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 26, 2025, 4:02 PM EDT - 9 months ago

GRAIL to Present at Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 13, 2025, 8:30 AM EDT - 9 months ago

GRAIL Transcript: Canaccord Genuity’s 45th Annual Growth Conference

Aug 12, 2025, 4:30 PM EDT - 9 months ago

GRAIL Earnings Call Transcript: Q2 2025

Aug 12, 2025, 4:02 PM EDT - 9 months ago

GRAIL Reports Second Quarter 2025 Financial Results

Jul 30, 2025, 4:02 PM EDT - 10 months ago

GRAIL to Present at Canaccord Genuity 45th Annual Growth Conference

Jul 29, 2025, 4:02 PM EDT - 10 months ago

GRAIL to Announce Second Quarter 2025 Financial Results

Jun 23, 2025, 5:30 AM EDT - 11 months ago

The Holy Grail of Automation: Now a Robot Can Unload a Truck

Jun 18, 2025, 12:43 PM EDT - 11 months ago

Grail Shares Jump on Promising Results for Galleri Study

Jun 18, 2025, 9:01 AM EDT - 11 months ago

GRAIL Announces Positive Top-Line Results From The Galleri® PATHFINDER 2 Registrational Study

Jun 4, 2025, 11:40 AM EDT - 1 year ago

GRAIL Transcript: Jefferies Global Healthcare Conference 2025

May 21, 2025, 4:05 PM EDT - 1 year ago

GRAIL to Present at Jefferies Global Healthcare Conference 2025

sam92 May. 8 at 11:17 AM

$GRAL Getting closer to real approval . This is on of those ready to Scandisk run !

0 · Reply

prodigy81 May. 7 at 8:27 PM

$CAI $BLLN $GRAL Do they have common in cancer diagonisic area right?

0 · Reply

joedoe007 May. 6 at 5:17 PM

$GRAL Will GRAL run like SNDK or $MU or even loke $CNC

1 · Reply

GoCoogs May. 6 at 3:13 PM

$GRAL 7 million shares are short. Will they start to cover?

0 · Reply

prodigy81 May. 5 at 9:25 PM

$GRAL Hmm...I don't think this earning is that bad....but somehow people don't like it?

0 · Reply

1cashmoney May. 5 at 9:13 PM

0 · Reply

sam92 May. 5 at 8:50 PM

0 · Reply

sam92 May. 5 at 8:49 PM

$GRAL GRAIL to Present at the BofA Securities 2026 Health Care Conference 04:01:00 PM ET, 04/30/2026 - PR Newswire

0 · Reply

StocktwitsEarnings May. 5 at 8:11 PM

$GRAL Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$2.29 up 26.13% YoY • Reported revenue of $40.78M up 28.11% YoY

0 · Reply

AStrokeOfLuck May. 5 at 8:07 PM

$GRAL

0 · Reply

OfficialStocktwitsUser May. 5 at 2:10 PM

$GRAL RSI: 61.13, MACD: 0.3516 Vol: 2.74, MA20: 51.48, MA50: 50.65 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

skuntmonkey May. 4 at 11:07 PM

$GRAL

0 · Reply

TheUnmaker May. 4 at 9:41 AM

$TNXP $GRAL $NBIS $PFE

0 · Reply

TheUnmaker May. 4 at 8:51 AM

$TNXP This will move like $GRAL when I was loading under $31 before the big run over $100. Same style setup.. rocket launch imminent. Don't get caught chasing and wishing you bought more.

1 · Reply

Bazzzigar May. 1 at 5:25 PM

$GRAL dumping before ER

0 · Reply

MarcoFla99 Apr. 29 at 2:08 PM

$GRAL New Batch $50.47

0 · Reply

FishermanStonks Apr. 29 at 1:14 PM

$GRAL my only regret was not buying enough puts. TY GRAL.

0 · Reply

POWELL_ Apr. 28 at 5:26 AM

$GRAL GROK

0 · Reply

AnthonyTradingWithJesus Apr. 26 at 10:45 PM

$BRK.A $BROS $TOP $FRO $GRAL

0 · Reply

MarcoFla99 Apr. 23 at 6:35 PM

$GRAL The MM on GRAL is a huge DBag imo. Trying to grab as many as they can before the ER on 5/5.

0 · Reply

SuperGreenToday Apr. 22 at 8:04 PM

$GRAL Share Price: $52.75 Contract Selected: Oct 16, 2026 $55 Calls Buy Zone: $9.69 – $11.97 Target Zone: $17.69 – $21.62 Potential Upside: 72% ROI Time to Expiration: 176 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

History101 Apr. 22 at 3:27 AM

$GRAL article mentions GRAL's failed trial: https://www.nbcnews.com/health/rcna341257

0 · Reply

Market Cap	2.69B
Revenue (ttm)	147.17M
Net Income (ttm)	-408.35M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-277.47%
Debt to Equity Ratio	0.00

Volume	537,275
Avg Vol	881,150
Day's Range	N/A - N/A
Shares Out	42.92M
Stochastic %K	89%
Beta	3.03
Analysts	Sell
Price Target	$67.71